Peptidyl conjugates of adenosine 5'-carboxylic acid synthesized and evaluated as ligands for P2 purinoceptors

Biochemical and Biophysical Research Communications

Volumn 229, Issue 2, 1996, Pages 363-369

  Järlebark, Leif ^a   Erlandsson, Mikael ^a   Uri, Asko ^a,b   King, Brian F ^c   Ziganshin, Airat U ^d   Johansson, Charlotta ^e   Heilbronn, Edith ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^e Swedish NMR Centre   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; CARBOXYLIC ACID DERIVATIVE; LIGAND; PEPTIDE; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER; CONJUGATE; GLIOMA CELL; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SYNTHESIS; VAS DEFERENS;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030582754     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1811     Document Type: Article

References (27)

1. 1. Benham, C. D., and Tsien, R. W. (1987) Nature 328, 275-278.
2. 2. Bean, B. P., and Friel, D. P. (1990) in Ion Channels (Narahachi, T., Ed.), Vol. 2, pp. 169-205, Plenum Press, New York.
3. 3. Harden, T. K., Boyer, J. L., and Nicholas, R. A. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 541-579.
4. 4. Chen, Z.-P., Levy, A., and Lightman, S. L. (1995) J. Neuroendocrinol. 7, 83-96.
5. 5. Häggblad, J., and Heilbronn, E. (1988) FEBS Lett. 235, 133-136.
6. 6. Nilles, R., Järlebark, L., Zenner, H. P., and Heilbronn, E. (1994) Hear. Res. 73, 27-34.
7. 7. Surprenant, A., Buell, G., and North, R. A. (1995) Trends. Neurosci. 18, 224-229.
8. 8. Burnstock, G., and King, B. F. (1996) Drug Dev. Res. 38, 67-71.
9. 9. Lustig, K. D., Shiau, A. K., Brake, A. J., and Julius, D. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 5113-5117.
10. 10. Barnard, E. A., Burnstock, G., and Webb, T. E. (1994) Trends Pharmacol. Sci. 15, 67-70.
11. 11. Uri, A., Järlebark, L., von Kügelgen, I., Schönberg, T., Undén, A., and Heilbronn, E. (1994) BioMed. Chem. 2, 1099-1105.
12. 12. Cusack, N. J., and Hourani, S. M. O. (1990) in Purines in Cellular Signalling: Targets for New Drugs (Jacobson, K. A., Daly, J. W., and Manganiello, V., Eds.), pp. 254-259, Springer-Verlag, New York.
13. 13. Zimmet, J., Järlebark, L., Hammarberg, T., van Galen, P. J. M., Jacobson, K. A., and Heilbronn, E. (1993) Nucleosides and Nucleotides 12, 1-20.
14. 14. Fischer, B., Boyer, J. L., Hoyle, C. H., Ziganshin, A. U., Brizzolara, A. L., Knight, G. E., Zimmet, J., Burnstock, G., Harden, T. K., and Jacobson, K. A. (1993) J. Med. Chem. 36, 3937-3946.
15. 15. Sieber, P. (1987) Tetrahedron Lett. 28, 6147-6150.
16. 16. Norris, J. S., Gorski, J., and Kohler, P. O. (1974) Nature 248, 422-424.
17. 17. Gerwins, P., and Fredholm, B. B. (1992) J. Biol. Chem. 267, 16081-16087.
18. 18. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450.
19. 19. Hoyle, C. H. V., and Edwards, G. A. (1992) Br. J. Pharmacol. 107, 367-374.
20. 20. Rubino, A., Thomann, H., Henlin, J.-M., Schilling, W., and Criscione, L. (1992) Eur. J. Pharmacol. 212, 237-240.
21. 21. Hoyle, C. H. V., Knight, G. E., and Burnstock, G. (1990) Br. J. Pharmacol. 99, 617-621.
22. 22. Erb, L., Garrad, R., Wang, Y., Quinn, T., Turner, J. T., and Weisman, G. A. (1995) J. Biol. Chem. 270, 4185-4188.
23. 23. Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., and Buell, G. (1994) Nature 371, 516-519.
24. 24. Valera, S., Talabot, F., Evans, R. J., Gos, A., Antonarakis, S. E., Morris, M. A., and Buell, G. N. (1995) Recept. Channels 3, 283-289.
25. 25. van Rhee, A. M., Fischer, B., van Galen, P. J. M., and Jacobson, K. A. (1995) Drug Design and Discovery 13, 133-154.
26. 26. Ziganshin, A. U., Ziganshina, L. E., King, B. F., and Burnstock, G. (1995) Pflügers Arch. 429, 412-418.
27. 27. King, B. F., Ziganshina, L. E., Pintor, J., and Burnstock, G. (1996) Br. J. Pharmacol. 117, 1371-1373.